Medicare Program; Emergency Medical Treatment and Labor Act (EMTALA) Technical Advisory Group (TAG) Meeting-June 15, 2005 Through June 17, 2005, 28541-28542 [05-9852]
Download as PDF
Federal Register / Vol. 70, No. 95 / Wednesday, May 18, 2005 / Notices
Dated: May 6, 2005.
Michael O. Leavitt,
Secretary.
[FR Doc. 05–9899 Filed 5–17–05; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1269–N4]
Medicare Program; Emergency Medical
Treatment and Labor Act (EMTALA)
Technical Advisory Group (TAG)
Meeting—June 15, 2005 Through June
17, 2005
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
SUMMARY: In accordance with section
10(a) of the Federal Advisory Committee
Act (FACA) (5 U.S.C. Appendix 2), this
notice announces the second meeting of
the Emergency Medical Treatment and
Labor Act (EMTALA) Technical
Advisory Group (TAG). The purpose of
the EMTALA TAG is to review
regulations affecting hospital and
physician responsibilities under
EMTALA to individuals who come to a
hospital seeking examination or
treatment for medical conditions. The
primary purpose of the second meeting
is to enable the EMTALA TAG to hear
testimony and consider written
responses from medical societies and
other organizations on specific issues
considered by the TAG at its initial
meeting. However, the public is
permitted to attend this meeting and, to
the extent that time permits and at the
discretion of the Chairperson, the
EMTALA TAG may hear comments
from the floor.
DATES: Meeting Dates: The meetings of
the EMTALA TAG announced in this
notice are as follows:
Wednesday, June 15, 2005, 11 a.m. to 5
p.m.
Thursday, June 16, 2005 from 9 a.m. to
5 p.m.
Friday, June 17, 2005 from 9 a.m. to 12
noon.
Registration and Deadline: You may
register by sending an e-mail to
EMTALATAG@cms.hhs.gov, sending a
fax to the attention of Ronda Allen at fax
number (410) 786–0681 or (410) 786–
0169, or calling (410) 786–4548. To
attend this meeting, all individuals must
register by June 8, 2005.
Comment Deadline: Comments to be
distributed to the EMTALA TAG may be
VerDate jul<14>2003
14:03 May 17, 2005
Jkt 205001
submitted in writing up to three
business days following the meeting. If
anyone wishes to submit written
comments, Beverly J. Parker must
receive the comments by 5 p.m., June
22, 2005 at the address listed below.
Special Accommodations: Individuals
requiring sign-language interpretation or
other special accommodations should
send a request for these services to
Beverley J. Parker by 5 p.m., June 1,
2005 at the address listed below.
ADDRESSES: Meeting Address: The
EMTALA TAG meeting will be held in
Room 705A at the Hubert H. Humphrey
Building, 200 Independence Avenue,
SW., Washington, DC 20201.
Mailing and Email Addresses for
Inquiries or Comments: Inquiries or
comments regarding this meeting may
be sent to—Beverly J. Parker, Division of
Acute Care, Centers for Medicare &
Medicaid Services, Mail Stop C4–08–06,
7500 Security Boulevard, Baltimore, MD
21244–1850. Inquiries or comments may
also be emailed to
EMTALATAG@cms.hhs.gov.
Web Site Address for Additional
Information: For additional information
on the EMTALA TAG meeting agenda
topics, updated activities, and to obtain
Charter copies, please search our
Internet Web site at: https://
www.cms.hhs.gov/faca/emtalatag/
emtalatagpage.asp.
FOR FURTHER INFORMATION CONTACT:
Beverly J. Parker at (410) 786–5320 or
George Morey at (410) 786–4653. Press
inquiries are handled through the CMS
Press Office at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1866(a)(1)(I), 1866(a)(1)(N),
and 1867 of the Social Security Act (the
Act) impose specific obligations on
Medicare-participating hospitals that
offer emergency services. These
obligations concern individuals who
come to a hospital emergency
department and request or have a
request made on their behalf for
examination or treatment for a medical
condition. EMTALA applies to all these
individuals, regardless of whether or not
they are beneficiaries of any program
under the Act. Section 1867 of the Act
sets forth requirements for medical
screening examinations for emergency
medical conditions, as well as necessary
stabilizing treatment or appropriate
transfer.
Regulations implementing the
EMTALA legislation are set forth at 42
CFR 489.20(l), (m), (q) and (r)(1), (r)(2),
(r)(3), and 489.24. Section 945 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
28541
2003 (MMA) (Pub. L. 108–173), requires
that the Secretary establish a Technical
Advisory Group (TAG) for advice
concerning issues related to EMTALA
regulations and implementation.
Section 945 of the MMA specifies that
the EMTALA TAG—
• Review the EMTALA regulations;
• Provide advice and
recommendations to the Secretary
concerning these regulations and their
application to hospitals and physicians;
• Solicit comments and
recommendations from hospitals,
physicians, and the public regarding
implementation of these regulations;
and
• Disseminate information
concerning the application of these
regulations to hospitals, physicians, and
the public.
The EMTALA TAG, as chartered
under the legal authority of section 945
of the MMA, is also governed by the
provisions of the Federal Advisory
Committee Act (FACA) (5 U.S.C.
Appendix 2) for the selection of
members and the conduct of all
meetings.
In the May 28, 2004 Federal Register
(69 FR 30654), we specified the
statutory requirements regarding the
charter, general responsibilities, and
structure of the EMTALA TAG. That
notice also solicited nominations for
members based on the statutory
requirements for the EMTALA TAG. We
received no nominations. In the August
27, 2004 Federal Register (69 FR
52699), we again solicited nominations
for members in two categories (patient
representatives and a State survey
agency representative.) In the March 15,
2005 Federal Register (70 FR 12691), we
announced the inaugural meeting of the
EMTALA TAG and the membership
selection.
II. Meeting Format, Agenda, and
Suggested Presentation Topics
A. Meeting Format
The initial portion of the meeting
(convening at 11 a.m. on June 15) will
involve opening remarks and
presentations by CMS staff, as requested
by the TAG, followed by testimony from
representatives of organizations invited
to present information on specific
topics. TAG members will have the
opportunity to ask questions, prioritize
the topics presented, and to conduct
other necessary business. At the
conclusion of each day’s meeting, to the
extent that time is available and at the
discretion of the Chairperson, the public
will be permitted a reasonable time to
comment on issues being considered by
the TAG.
E:\FR\FM\18MYN1.SGM
18MYN1
28542
Federal Register / Vol. 70, No. 95 / Wednesday, May 18, 2005 / Notices
B. Tentative Meeting Agenda
The tentative agenda for the EMTALA
TAG meetings is as follows:
Day 1
Convenes at 11 a.m.
Welcome, call to order, and opening
remarks
• Administrative and housekeeping
issues
• CMS staff presentations on
EMTALA
Presentations by invited organizations
concerning:
• On-call/transfer issues
• Nurse-midwife responsibilities
under EMTALA
• Public comment
Adjourns at 5 p.m.
Day 2
Convenes at 9 a.m.
Presentations by invited organizations
(cont’d)
• Subcommittee reports
• Discussion of current business
• Public comment
Adjourns at 5 p.m.
Day 3
Convenes at 9 a.m.
Discussion of current business (cont’d)
Adjourns at 12 noon
III. Registration Instructions
While there is no registration fee,
individuals must register to attend. As
specified in the DATES section of this
notice, individuals who wish to attend
the meeting must register by June 8,
2005. You may register by sending an email to EMTALATAG@cms.hhs.gov,
sending a fax to the attention of Ronda
Allen at fax number (410) 786–0681 or
(410) 786–0169, or calling (410) 786–
4548. All registration requests must
include your name, name of the
organization (if applicable), address,
telephone and fax numbers, e-mail
address (if available). You will receive
a registration confirmation with
instructions for your arrival at the
Hubert H. Humphrey Building. If
seating capacity has been reached, you
will be notified that the meeting has
reached capacity. All registrants are
asked to arrive at the Humphrey
Building no later than 20 minutes before
the scheduled starting time of each
meeting session they wish to attend.
Authority: Section 945 of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
IV. Security Information
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Since this meeting will be held in a
Federal government building, Federal
security measures are applicable. As
noted above, in planning your arrival
time, we recommend allowing
additional time to clear security. In
order to gain access to the building,
participants must bring a governmentissued photo identification (for instance,
a driver’s license or passport) and a
copy of your confirmation of registration
for the meeting. Access may be denied
to persons without proper
identification.
All persons entering the building
must pass through a metal detector. In
addition, all items brought to the
building, whether personal, or for the
purpose of demonstration, or to support
a presentation are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
demonstration or to support a
presentation.
Number of
respondents
Instrument
Survey ..............................................................................................................
Estimated Total Annual Burden
Hours: 104 hours.
Additional Information: ACF is
requesting that OMB grant a 90-day
approval for this information collection
under procedures for emergency
processing by May 18, 2005. A copy of
this information collection, with
applicable supporting documentation,
may be obtained by calling Greta
Johnson at the Administration for
Children and Families at (202) 401–
9384. In addition, a request may be
made by sending an e-mail request to:
grjohnson@acf.hhs.gov.
VerDate jul<14>2003
14:03 May 17, 2005
Jkt 205001
Dated: May 12, 2005.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 05–9911 Filed 5–17–05; 8:45 am]
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
BILLING CODE 4120–01–P
Administration for Children and
Families
Agency Recordkeeping/Reporting
Requirements Under Emergency
Review by the Office of Management
and Budget (OMB)
Title: Survey of State Practices and
Policies Regarding Participation of
Children in Foster Care in Clinical Drug
Trials.
OMB No.: New Request.
Description: The Administration for
Children and Families is requesting
State child welfare agencies to
voluntarily complete a survey to
ascertain States’ policies and practices
related to children in foster care
participating in clinical drug trials. This
information collection is in response to
a Congressional inquiry.
Respondents: State child welfare
agencies.
Annual Burden Estimates:
Number of
responses per
respondent
52
Comments and questions about the
information collection described above
should be directed to the following
address by May 18, 2005: Office of
Information and Regulatory Affairs,
Office of Management and Budget,
Paperwork Reduction Project, Desk
Officer for ACF, Attention E-mail:
Katherine_T._Astrich@omb.eop.gov.
BILLING CODE 4184–01–M
Dated: May 10, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–9852 Filed 5–17–05; 8:45 am]
1
Average
burden hour
per response
Total burden
hours
2
104
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families Office of Community
Services; Grant to the Rural
Community Assistance Program
Office of Community Services,
Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
ACTION: Award announcement.
AGENCY:
CFDA #: The Catalog of Federal
Domestic Assistance (CFDA) number for
this program is 93.570. The title is Rural
E:\FR\FM\18MYN1.SGM
18MYN1
Agencies
[Federal Register Volume 70, Number 95 (Wednesday, May 18, 2005)]
[Notices]
[Pages 28541-28542]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9852]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1269-N4]
Medicare Program; Emergency Medical Treatment and Labor Act
(EMTALA) Technical Advisory Group (TAG) Meeting--June 15, 2005 Through
June 17, 2005
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a) of the Federal Advisory
Committee Act (FACA) (5 U.S.C. Appendix 2), this notice announces the
second meeting of the Emergency Medical Treatment and Labor Act
(EMTALA) Technical Advisory Group (TAG). The purpose of the EMTALA TAG
is to review regulations affecting hospital and physician
responsibilities under EMTALA to individuals who come to a hospital
seeking examination or treatment for medical conditions. The primary
purpose of the second meeting is to enable the EMTALA TAG to hear
testimony and consider written responses from medical societies and
other organizations on specific issues considered by the TAG at its
initial meeting. However, the public is permitted to attend this
meeting and, to the extent that time permits and at the discretion of
the Chairperson, the EMTALA TAG may hear comments from the floor.
DATES: Meeting Dates: The meetings of the EMTALA TAG announced in this
notice are as follows:
Wednesday, June 15, 2005, 11 a.m. to 5 p.m.
Thursday, June 16, 2005 from 9 a.m. to 5 p.m.
Friday, June 17, 2005 from 9 a.m. to 12 noon.
Registration and Deadline: You may register by sending an e-mail to
EMTALATAG@cms.hhs.gov, sending a fax to the attention of Ronda Allen at
fax number (410) 786-0681 or (410) 786-0169, or calling (410) 786-4548.
To attend this meeting, all individuals must register by June 8, 2005.
Comment Deadline: Comments to be distributed to the EMTALA TAG may
be submitted in writing up to three business days following the
meeting. If anyone wishes to submit written comments, Beverly J. Parker
must receive the comments by 5 p.m., June 22, 2005 at the address
listed below.
Special Accommodations: Individuals requiring sign-language
interpretation or other special accommodations should send a request
for these services to Beverley J. Parker by 5 p.m., June 1, 2005 at the
address listed below.
ADDRESSES: Meeting Address: The EMTALA TAG meeting will be held in Room
705A at the Hubert H. Humphrey Building, 200 Independence Avenue, SW.,
Washington, DC 20201.
Mailing and Email Addresses for Inquiries or Comments: Inquiries or
comments regarding this meeting may be sent to--Beverly J. Parker,
Division of Acute Care, Centers for Medicare & Medicaid Services, Mail
Stop C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850.
Inquiries or comments may also be emailed to EMTALATAG@cms.hhs.gov.
Web Site Address for Additional Information: For additional
information on the EMTALA TAG meeting agenda topics, updated
activities, and to obtain Charter copies, please search our Internet
Web site at: https://www.cms.hhs.gov/faca/emtalatag/emtalatagpage.asp.
FOR FURTHER INFORMATION CONTACT: Beverly J. Parker at (410) 786-5320 or
George Morey at (410) 786-4653. Press inquiries are handled through the
CMS Press Office at (202) 690-6145.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1866(a)(1)(I), 1866(a)(1)(N), and 1867 of the Social
Security Act (the Act) impose specific obligations on Medicare-
participating hospitals that offer emergency services. These
obligations concern individuals who come to a hospital emergency
department and request or have a request made on their behalf for
examination or treatment for a medical condition. EMTALA applies to all
these individuals, regardless of whether or not they are beneficiaries
of any program under the Act. Section 1867 of the Act sets forth
requirements for medical screening examinations for emergency medical
conditions, as well as necessary stabilizing treatment or appropriate
transfer.
Regulations implementing the EMTALA legislation are set forth at 42
CFR 489.20(l), (m), (q) and (r)(1), (r)(2), (r)(3), and 489.24. Section
945 of the Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (MMA) (Pub. L. 108-173), requires that the Secretary
establish a Technical Advisory Group (TAG) for advice concerning issues
related to EMTALA regulations and implementation.
Section 945 of the MMA specifies that the EMTALA TAG--
Review the EMTALA regulations;
Provide advice and recommendations to the Secretary
concerning these regulations and their application to hospitals and
physicians;
Solicit comments and recommendations from hospitals,
physicians, and the public regarding implementation of these
regulations; and
Disseminate information concerning the application of
these regulations to hospitals, physicians, and the public.
The EMTALA TAG, as chartered under the legal authority of section
945 of the MMA, is also governed by the provisions of the Federal
Advisory Committee Act (FACA) (5 U.S.C. Appendix 2) for the selection
of members and the conduct of all meetings.
In the May 28, 2004 Federal Register (69 FR 30654), we specified
the statutory requirements regarding the charter, general
responsibilities, and structure of the EMTALA TAG. That notice also
solicited nominations for members based on the statutory requirements
for the EMTALA TAG. We received no nominations. In the August 27, 2004
Federal Register (69 FR 52699), we again solicited nominations for
members in two categories (patient representatives and a State survey
agency representative.) In the March 15, 2005 Federal Register (70 FR
12691), we announced the inaugural meeting of the EMTALA TAG and the
membership selection.
II. Meeting Format, Agenda, and Suggested Presentation Topics
A. Meeting Format
The initial portion of the meeting (convening at 11 a.m. on June
15) will involve opening remarks and presentations by CMS staff, as
requested by the TAG, followed by testimony from representatives of
organizations invited to present information on specific topics. TAG
members will have the opportunity to ask questions, prioritize the
topics presented, and to conduct other necessary business. At the
conclusion of each day's meeting, to the extent that time is available
and at the discretion of the Chairperson, the public will be permitted
a reasonable time to comment on issues being considered by the TAG.
[[Page 28542]]
B. Tentative Meeting Agenda
The tentative agenda for the EMTALA TAG meetings is as follows:
Day 1
Convenes at 11 a.m.
Welcome, call to order, and opening remarks
Administrative and housekeeping issues
CMS staff presentations on EMTALA
Presentations by invited organizations concerning:
On-call/transfer issues
Nurse-midwife responsibilities under EMTALA
Public comment
Adjourns at 5 p.m.
Day 2
Convenes at 9 a.m.
Presentations by invited organizations (cont'd)
Subcommittee reports
Discussion of current business
Public comment
Adjourns at 5 p.m.
Day 3
Convenes at 9 a.m.
Discussion of current business (cont'd)
Adjourns at 12 noon
III. Registration Instructions
While there is no registration fee, individuals must register to
attend. As specified in the DATES section of this notice, individuals
who wish to attend the meeting must register by June 8, 2005. You may
register by sending an e-mail to EMTALATAG@cms.hhs.gov, sending a fax
to the attention of Ronda Allen at fax number (410) 786-0681 or (410)
786-0169, or calling (410) 786-4548. All registration requests must
include your name, name of the organization (if applicable), address,
telephone and fax numbers, e-mail address (if available). You will
receive a registration confirmation with instructions for your arrival
at the Hubert H. Humphrey Building. If seating capacity has been
reached, you will be notified that the meeting has reached capacity.
All registrants are asked to arrive at the Humphrey Building no later
than 20 minutes before the scheduled starting time of each meeting
session they wish to attend.
IV. Security Information
Since this meeting will be held in a Federal government building,
Federal security measures are applicable. As noted above, in planning
your arrival time, we recommend allowing additional time to clear
security. In order to gain access to the building, participants must
bring a government-issued photo identification (for instance, a
driver's license or passport) and a copy of your confirmation of
registration for the meeting. Access may be denied to persons without
proper identification.
All persons entering the building must pass through a metal
detector. In addition, all items brought to the building, whether
personal, or for the purpose of demonstration, or to support a
presentation are subject to inspection. We cannot assume responsibility
for coordinating the receipt, transfer, transport, storage, set-up,
safety, or timely arrival of any personal belongings or items used for
demonstration or to support a presentation.
Authority: Section 945 of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: May 10, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-9852 Filed 5-17-05; 8:45 am]
BILLING CODE 4120-01-P